| Effect of Materials for Subcuticular Suture (Quill vs. Monocryl) on Complications After Liver Resection (NCT04906174) | M.D. Anderson Cancer Center | 2021-04-10 |
| Fludarabine, Cytarabine, and Pegcrisantaspase for the Treament of Relapsed or Refractory Leukemia (NCT04526795) | M.D. Anderson Cancer Center | 2021-04-09 |
| An Imaging Technology, Contrast-Enhanced Mammography, in Predicting Breast Cancer (NCT04871139) | M.D. Anderson Cancer Center | 2021-04-08 |
| NBTXR3, Radiation Therapy, and Pembrolizumab for the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Cancer (NCT04862455) | M.D. Anderson Cancer Center | 2021-04-07 |
| Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT) (NCT03460769) | M.D. Anderson Cancer Center | 2021-04-01 |
| Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study (NCT06651580) | M.D. Anderson Cancer Center | 2021-04-01 |
| Three-Dimensional Fluoroscopic Guidance During Transbronchial Cryobiopsy (NCT05059691) | M.D. Anderson Cancer Center | 2021-03-30 |
| Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis (NCT04870645) | M.D. Anderson Cancer Center | 2021-03-30 |
| Positron Emission Tomography for the Diagnosis of Immune Checkpoint Inhibitor-Related Myocarditis (NCT05062395) | M.D. Anderson Cancer Center | 2021-03-30 |
| Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies (NCT04785287) | M.D. Anderson Cancer Center | 2021-03-29 |
| Pevonedistat and Pembrolizumab for the Treatment of dMMR/MSI-H Metastatic or Locally Advanced Unresectable Solid Tumor (NCT04800627) | M.D. Anderson Cancer Center | 2021-03-29 |
| A Prospective Pilot Study for the Evaluation of 18F- Fluciclovine PET/MRI in Radio-recurrent Prostate Cancer (RRPC-PET/MRI Study) (NCT05035732) | M.D. Anderson Cancer Center | 2021-03-25 |
| DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (NCT04752163) | M.D. Anderson Cancer Center | 2021-03-25 |
| Mindfulness-Based Intervention for Latino Cancer Patients and Their Caregivers (NCT04870788) | M.D. Anderson Cancer Center | 2021-03-24 |
| Rice Technologies for Cervical Cancer Screening and Diagnosis (NCT05372484) | M.D. Anderson Cancer Center | 2021-03-24 |
| EXPAREL or Lidocane as Local Anesthetic in Patients Undergoing Pleuroscopy With Pleural Biopsy and Indwelling Pleural Catheter Placement (NCT05044468) | M.D. Anderson Cancer Center | 2021-03-23 |
| Contrast-Enhanced Mammography for the Evaluation of Mammographic Microcalcifications (NCT05046301) | M.D. Anderson Cancer Center | 2021-03-23 |
| Contrast-Enhanced Mammography for Breast Cancer Staging in Patients Referred for a Second Opinion (NCT05036083) | M.D. Anderson Cancer Center | 2021-03-19 |
| Ensartinib, Carboplatin, Pemetrexed and Bevacizumab for the Treatment of Stage IIIC or IV or Recurrent ALK-Positive Non-small Cell Lung Cancer (NCT04837716) | M.D. Anderson Cancer Center | 2021-03-18 |
| Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases, the CROME Trial (NCT04693377) | M.D. Anderson Cancer Center | 2021-03-16 |
| Patient Reported Outcome Post Radiation Therapy or Chemoradiotherapy Patient Care in Patients With Oropharyngeal Cancer (NCT04874493) | M.D. Anderson Cancer Center | 2021-03-10 |
| Re-irradiation With NBTXR3 in Combination With Pembrolizumab for the Treatment of Inoperable Locoregional Recurrent Head and Neck Squamous Cell Cancer (NCT04834349) | M.D. Anderson Cancer Center | 2021-03-09 |
| Immunotherapy (NHS-IL12 & Bintrafusp Alfa) and Radiation Therapy for the Treatment of Hormone Receptor Positive, HER2 Negative Metastatic Breast Cancer, the REINA Trial (NCT04756505) | M.D. Anderson Cancer Center | 2021-03-07 |
| An Exercise and Nutrition Monitoring Intervention (Pt Pal) for the Improvement of Strength in Patients With Pancreatic or Stomach Cancer Receiving Chemoradiation Therapy Before Surgery, SurgeryStrong Study (NCT05056805) | M.D. Anderson Cancer Center | 2021-03-04 |
| Interrogating Biological Signaling Pathway Dysregulations and In Vitro Screening With Personalized Therapies in Relapsed or Refractory Mantle Cell Lymphoma, MCL MATCH Trial (NCT04872413) | M.D. Anderson Cancer Center | 2021-03-04 |
| Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome (NCT04776876) | M.D. Anderson Cancer Center | 2021-03-01 |
| Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer (NCT04759911) | M.D. Anderson Cancer Center | 2021-02-26 |
| A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP (NCT04740164) | M.D. Anderson Cancer Center | 2021-02-24 |
| Venetoclax and ASTX727 for the Treatment of Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia (NCT04746235) | M.D. Anderson Cancer Center | 2021-02-22 |
| Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders (NCT04729322) | M.D. Anderson Cancer Center | 2021-02-22 |
| Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer (NCT03819296) | M.D. Anderson Cancer Center | 2021-02-21 |
| Sapanisertib and Nivolumab for the Treatment of Stage I-IV Non-small Cell Lung Cancer in Patients Who Have Progressed on Prior PD-1/PD-L1 Inhibitor Therapy, I-OVERCOME Study (NCT05022394) | M.D. Anderson Cancer Center | 2021-02-18 |
| Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease (NCT04744116) | M.D. Anderson Cancer Center | 2021-02-17 |
| Resistance Training Intervention to Improve Physical Function in Patients With Pancreatic Cancer Receiving Combination Chemotherapy or Have Undergone Surgery, PancStrength Study (NCT04837118) | M.D. Anderson Cancer Center | 2021-02-15 |
| NBTXR3 and Radiation Therapy for the Treatment of Inoperable Recurrent Non-small Cell Lung Cancer (NCT04505267) | M.D. Anderson Cancer Center | 2021-02-10 |
| Atezolizumab and Bevacizumab Before Surgery for the Treatment of Resectable Liver Cancer (NCT04721132) | M.D. Anderson Cancer Center | 2021-02-10 |
| Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis (NCT04517851) | M.D. Anderson Cancer Center | 2021-02-10 |
| SAR439459 and Cemiplimab for the Treatment of Advanced or Unresectable Solid Tumors, Strategic Alliance, TACTIC TRIAL (NCT04729725) | M.D. Anderson Cancer Center | 2021-02-09 |
| Patient Reported Symptom Control With THC or CBD Use (NCT04875286) | M.D. Anderson Cancer Center | 2021-02-03 |
| Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients (NCT04038619) | M.D. Anderson Cancer Center | 2021-02-01 |
| Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas (NCT04701307) | M.D. Anderson Cancer Center | 2021-02-01 |
| Dyadic Yoga Intervention for the Improvement of Healthcare Utilization and Quality of Life in Patients With Head and Neck Cancer Undergoing Chemoradiation and Their Caregivers (NCT04890834) | M.D. Anderson Cancer Center | 2021-01-28 |
| iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation (NCT03608631) | M.D. Anderson Cancer Center | 2021-01-27 |
| Ultrasound-Guided Photoacoustic Imaging for the Detection of Metastases in Inguinal Lymph Nodes (NCT04185337) | M.D. Anderson Cancer Center | 2021-01-26 |
| Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer (NCT04913311) | M.D. Anderson Cancer Center | 2021-01-21 |
| What Women Want: Real Time Results During Screening Mammography in the Era of Patient-Experience Driven Care (NCT04794816) | M.D. Anderson Cancer Center | 2021-01-21 |
| Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors (NCT04771520) | M.D. Anderson Cancer Center | 2021-01-20 |
| Venetoclax in Combination With ASTX727 for the Treatment of Treatment-Naive High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (NCT04655755) | M.D. Anderson Cancer Center | 2021-01-19 |
| Bintrafusp Alfa and Pimasertib for the Treatment of Patients With Brain Metastases (NCT04789668) | M.D. Anderson Cancer Center | 2021-01-15 |
| Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer (NCT04521946) | M.D. Anderson Cancer Center | 2021-01-14 |
| Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer (NCT04380545) | M.D. Anderson Cancer Center | 2021-01-13 |
| Single Fraction or Multi-fraction Palliative Radiation Therapy for the Improvement of Quality of Life in Patients With Metastatic Gynecologic Cancers (NCT04516135) | M.D. Anderson Cancer Center | 2021-01-11 |
| Olaparib and Durvalumab With Carboplatin, Etoposide, and/or Radiation Therapy for the Treatment of Extensive-Stage Small Cell Lung Cancer, PRIO Trial (NCT04728230) | M.D. Anderson Cancer Center | 2021-01-05 |
| Impact of Aminoglycosides in Hypotensive Septic Oncology Patients (NCT05045963) | M.D. Anderson Cancer Center | 2021-01-04 |
| CPX-351 and Ivosidenib for the Treatment of IDH1 Mutated Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome (NCT04493164) | M.D. Anderson Cancer Center | 2020-12-30 |
| Cabazitaxel, Carboplatin, and Cetrelimab Followed by Niraparib With or Without Cetrelimab for the Treatment of Aggressive Variant Metastatic Prostate Cancer (NCT04592237) | M.D. Anderson Cancer Center | 2020-12-29 |
| Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies (NCT04776850) | M.D. Anderson Cancer Center | 2020-12-29 |
| Evaluating the Impact of Limited Compared With Intense Post-Operative Surveillance on Patient-Reported Outcomes in Patients With Stage II-III Soft Tissue Sarcoma of the Trunk and Extremities (NCT04751409) | M.D. Anderson Cancer Center | 2020-12-28 |
| Surveys, Blood Testing, and Fibroscan in Screening for Liver Fibrosis and Liver Cirrhosis (NCT04785534) | M.D. Anderson Cancer Center | 2020-12-22 |
| Patient Considerations of Social Media Account Management After Death (NCT05035667) | M.D. Anderson Cancer Center | 2020-12-22 |
| Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique (NCT05359016) | M.D. Anderson Cancer Center | 2020-12-22 |
| Viral Specific T Cell Therapy for COVID-19 Related Pneumonia (NCT04742595) | M.D. Anderson Cancer Center | 2020-12-18 |
| Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics (NCT05056818) | M.D. Anderson Cancer Center | 2020-12-15 |
| Parental Attitudes and Beliefs Regarding Risks Associated With Opioid Use in Children With Cancer (NCT05055011) | M.D. Anderson Cancer Center | 2020-12-03 |
| Palliative, Rehabilitation, and Integrated Medicine Handbook for Self Care at Work (NCT05038384) | M.D. Anderson Cancer Center | 2020-12-03 |
| Exercise During Chemotherapy in Older Women With Stage I-III Breast Cancer (NCT05025059) | M.D. Anderson Cancer Center | 2020-12-03 |
| LY3214996 and Cetuximab Alone or in Combination With Abemaciclib for the Treatment of Unresectable or Metastatic Colorectal Cancer (NCT04616183) | M.D. Anderson Cancer Center | 2020-12-02 |
| Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial (NCT04693468) | M.D. Anderson Cancer Center | 2020-12-01 |
| Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study (NCT04783168) | M.D. Anderson Cancer Center | 2020-11-30 |
| Oleclumab and Durvalumab for the Treatment of Recurrent, Refractory, or Metastatic Sarcoma (NCT04668300) | M.D. Anderson Cancer Center | 2020-11-26 |
| Androgen Deprivation Therapy and Apalutamide With or Without Radiation Therapy for the Treatment of Biochemically Recurrent Prostate Cancer, RESTART Study (NCT04585932) | M.D. Anderson Cancer Center | 2020-11-24 |
| NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal Cancer (NCT04615013) | M.D. Anderson Cancer Center | 2020-11-23 |
| Medical Data Collection for the Evaluation of Radiofrequency Ablation and Cement Augmentation for the Treatment of Secondary Metastases to the Spine (NCT04751422) | M.D. Anderson Cancer Center | 2020-11-13 |
| Exercise Program (TEAM Me) for the Improvement of Movement and Mobility in Pediatric and Adolescent and Young Adult Patients With Cancer Undergoing a Blood Stem Cell Transplant (NCT04678427) | M.D. Anderson Cancer Center | 2020-11-13 |
| The Impact of COVID-19 on Pulmonary Procedures (NCT05022446) | M.D. Anderson Cancer Center | 2020-11-11 |
| Fentanyl Buccal Tablet or Morphine for Exertional Dyspnea in Cancer Patients (NCT04188418) | M.D. Anderson Cancer Center | 2020-10-23 |
| Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer (NCT04870840) | M.D. Anderson Cancer Center | 2020-10-19 |
| SX-682 and Nivolumab for the Treatment of RAS-Mutated, MSS Unresectable or Metastatic Colorectal Cancer, the STOPTRAFFIC-1 Trial (NCT04599140) | M.D. Anderson Cancer Center | 2020-10-14 |
| A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial (NCT04580771) | M.D. Anderson Cancer Center | 2020-10-14 |
| Patient-Specific Decision Aid System for Shared Decision Making About Breast Reconstruction (NCT05130580) | M.D. Anderson Cancer Center | 2020-10-13 |
| Alvocidib in Combination With Decitabine and Venetoclax in Patients With Relapsed or Refractory AML or as Frontline Therapy in Unfit Patients With AML (NCT04493099) | M.D. Anderson Cancer Center | 2020-10-01 |
| Role of Diet on the Microbiome of the Digestive System (NCT04666727) | M.D. Anderson Cancer Center | 2020-09-29 |
| 2018-0674 - IL-7 for T-Cell Recovery Post Haplo and CB Transplant - Phase I/II (NCT03941769) | M.D. Anderson Cancer Center | 2020-09-29 |
| ALI Post Radiation Therapy in Patients With Lung and Esophageal Canter (NCT04668833) | M.D. Anderson Cancer Center | 2020-09-29 |
| Step Count Monitoring as a Measure of Physical Activity in Patients With Newly Diagnosed Glioma Undergoing Radiation Therapy (NCT04186832) | M.D. Anderson Cancer Center | 2020-09-28 |
| Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation (NCT04127721) | M.D. Anderson Cancer Center | 2020-09-22 |
| Phase I Trial of DNA-PK Inhibitor (PEPOSERTIB ) in Combination With Radiation and Adjuvant Temozolomide in Newly Diagnosed MGMT Unmethylated and Recurrent Glioblastoma (NCT04555577) | M.D. Anderson Cancer Center | 2020-09-20 |
| Pembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer (NCT04522336) | M.D. Anderson Cancer Center | 2020-09-16 |
| Feasibility Study of Anatomical Modeling for Image Guided Thoracic Surgery (NCT05046067) | M.D. Anderson Cancer Center | 2020-09-16 |
| The Rise in Robotic Atypical Segmentectomies (NCT04644952) | M.D. Anderson Cancer Center | 2020-09-15 |
| Alisertib and Pembrolizumab for the Treatment of Patients With Rb-deficient Head and Neck Squamous Cell Cancer (NCT04555837) | M.D. Anderson Cancer Center | 2020-09-15 |
| Financial Toxicity in Cancer Patients (NCT04592250) | M.D. Anderson Cancer Center | 2020-09-12 |
| Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain (NCT04296305) | M.D. Anderson Cancer Center | 2020-09-10 |
| The Impact of an Antibiotic (Cefazolin) Before Surgery on the Microbiome in Patients With Stage I-II Melanoma (NCT04875728) | M.D. Anderson Cancer Center | 2020-09-08 |
| Venetoclax and Azacitidine for the Treatment of Relapsed or Refractory High-Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia (NCT04550442) | M.D. Anderson Cancer Center | 2020-09-04 |
| An Investigational Scan (7T MRI) for the Imaging of Central Nervous System Tumors (NCT04539574) | M.D. Anderson Cancer Center | 2020-09-04 |
| Home-Based Neurofeedback Program in Treating Participants With Chemotherapy-Induced Peripheral Neuropathy (NCT03436680) | M.D. Anderson Cancer Center | 2020-09-01 |
| Stereotactic Radiosurgery for the Treatment of Patients With Small Cell Lung Cancer Brain Metastasis (NCT04516070) | M.D. Anderson Cancer Center | 2020-08-28 |
| Evaluating Clonogenic Epithelial Cell Populations in Patients With Bronchiolitis Obliterans Syndrome (NCT04604522) | M.D. Anderson Cancer Center | 2020-08-27 |
| A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia (NCT04239157) | M.D. Anderson Cancer Center | 2020-08-25 |